Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1673 |
|---|---|
| Identifier | NCT02087878 |
| Trial Title | A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Ulcerative Colitis (UC)|Hepatosplenic T-Cell Lymphoma |
| Interventions | - |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Pisa |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2014-03-31 |
|---|---|
| Primary Completion Date | 2019-09-30 |
| Completion Date | 2019-09-30 |